Diarrhea

Analysis of Google search trends correlated with increases in COVID-19 cases several weeks before any actual spike, according to study results.

Minesapride, an agonist of 5-hydroxytryptamine 4 receptor, was safe and well-tolerated among patients with constipation-predominant irritable bowel syndrome, according to study results.

A 2-year-old girl with a history of maple syrup urine disease presented to the dermatology clinic with an ongoing diaper rash.

While gastrointestinal symptoms like anorexia and diarrhea are common in both patients with COVID-19 and those without, these symptoms plus a loss of smell, taste and fever were 99% specific for COVID-19, according to a study published in Gastroenterology.

The American Gastroenterological Association released guidance on consultative management of COVID-19 among patients with gastrointestinal and liver manifestations.

The first COVID-19 related story concerned with gastroenterology was published in Healio Gastroenterology and Liver Disease on March 6. Since then, we have published more than a dozen articles and posted numerous videos from leaders in the GI community about how the pandemic has impacted clinical practice and how it might change things going forward.

As of April 2, just 1.7% of confirmed cases of COVID-19 in the United States occurred in children, with more males than females being infected, according to new data published in MMWR.

Patients who develop new-onset digestive symptoms, like diarrhea, after a possible exposure to COVID-19 should be suspected for the illness, according to research published in The American Journal of Gastroenterology.

The top story in gastroenterology last week was about a study that showed digestive symptoms were common in patients with COVID-19.

Digestive symptoms were common in patients with COVID-19, according to the American Journal of Gastroenterology. Patients with these symptoms had a longer time from onset to admission and their prognosis was worse compared with patients without symptoms.